BIOAGE LABS, INC. — Income Charts
7 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$3M
R&D↑+27.4% +$5M
$25M
D&A↑+0.0% +$0
$100K
Operating Income↑+6.5% +$2M
$-23M
EBITDA↑+0.0% +$0
$100K
Interest Expense↓-71.2% -$227K
$92K
Net Income↑+13.8% +$3M
$-20M
Operating Margin
-1126.6%
Net Margin
-982.0%
ETR (Continuing Operations)↑+0.0pts
0.0%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↓-0.4pts
0.1%
Operating Lease Cost↑+100.0% +$100K
$200K
Income YoY Variation↑+156.8pts
6.5%
Revenue QoQ Variation
49.9%
Income QoQ Variation↑+68.7pts
6.6%